QA: Skye Bioscience Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2018_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001516551')"}

Graph

Absolute values for 0001516551, Skye Bioscience Inc.

  xvar xval
0 AssetsCurrent 555,811
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,407
3 remainder_Assets 0
4 LiabilitiesCurrent 805,974
5 LiabilitiesNoncurrent 551,322
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,547,927
9 ResearchAndDevelopmentExpense 311,302
10 remainder_Expenses -558,719
11 remainder_Revenues 0
12 remainder_NetIncome 206,212
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 557,218
1 Liabilities 1,357,296
2 Expenses 3,300,510
3 Revenues 0
4 StockholdersEquity -800,078
5 NetIncome -3,094,298
6 ComprehensiveNetIncome -3,094,298
7 BaseVar 2,710,618
8 EconomicCapitalRatio -4.67

Edgar->Model Mapping

Feature Distribution

Change over Time